Niva bupa health insurance company Limited has announced its participation in an investor interaction organized by ICICI Securities, scheduled for March 30, 2026. The company informed both the National Stock Exchange of India Limited and BSE Limited about this engagement through a regulatory filing dated March 24, 2026.

Meeting Details

The investor interaction is structured as a group meeting and will take place at Grand Hyatt, Santacruz, Mumbai. Company representatives will participate in this engagement to interact with analysts and investors.

Regulatory Compliance

The company has emphasized its commitment to regulatory compliance by stating that no unpublished price sensitive information will be shared during the meeting. This disclosure was made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Important Considerations

Niva Bupa Health Insurance Company Limited has noted that the meeting schedule is subject to potential changes due to exigencies that may arise from the part of analysts, investors, or the company itself. This flexibility clause ensures that all parties can accommodate any unforeseen circumstances that might affect the scheduled interaction.

The communication was signed by Aparna Sharma, Company Secretary and Compliance Officer, and was digitally authenticated on March 24, 2026, at 17:52:45 +05'30'.

Niva Bupa Health Insurance Company Limited has disclosed receiving a significant income tax demand notice from Mumbai tax authorities, marking a notable regulatory development for the health insurance provider.

Income Tax Demand Details

The company received an Order cum Notice of Demand under Section 156 read with Section 143(3) of the Income Tax Act, 1961, from the Office of the Assistant Commissioner of Income Tax, Central Circle 5(3), Mumbai, on March 14, 2026. The demand pertains to Assessment Year 2023-24 and involves substantial financial implications.

Primary Reasons for Tax Demand

The Assessing Officer made additions to the company's total taxable income through specific adjustments that primarily focus on two key areas:

• Marketing and Advertisement Expenses: Disallowance of certain marketing and advertisement expenses deemed inadmissible under Section 37(1) of the Income Tax Act
• Insurance Provisions: Disallowance of provisions for claims Incurred But Not Reported (IBNR) and claims Incurred But Not Enough Reported (IBNER)

The company has noted that these disallowances primarily relate to industry-wide issues, suggesting similar challenges may affect other health insurance providers.

Company's Response and Next Steps

Niva Bupa Health Insurance has outlined its planned course of action in response to the tax demand. The company emphasized that the order is appealable and confirmed it will exercise its right to appeal before the Appellate Authorities. Additionally, the company has committed to making appropriate disclosures in its financial statements as required by regulatory standards.

Regulatory Compliance

The disclosure was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, demonstrating the company's commitment to transparency with stakeholders. The communication was formally submitted to both the National Stock Exchange of India Limited and BSE Limited, ensuring comprehensive market notification of this material development.